Loading
Latest filing published 02 Aug 2016 for INTERLEUKIN GENETICS INC, €1.8M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Only one filing by Growth Equity Opportunities Fund III, LLC is known so far (2 August 2016): an open-market purchase, €1.8M, in Interleukin Genetics Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by M. James Barrett, counted once
1 of 0 declarations